| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe
|
Ristić, Smiljana
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 2 |
An observed association between conjunctivitis and severity of COVID-19
|
Loffredo, Lorenzo
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 3 |
A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
|
Xie, Dongying
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 4 |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
|
Gudiol, C.
|
|
|
83 |
3 |
p. 306-313
|
article
|
| 5 |
Crossing the Rubicon: A fine line between waiting and vaccinating adolescents against COVID-19
|
Ladhani, Shamez N
|
|
|
83 |
3 |
p. 294-297
|
article
|
| 6 |
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study
|
Stanzani, Marta
|
|
|
83 |
3 |
p. 371-380
|
article
|
| 7 |
Editorial Board
|
|
|
|
83 |
3 |
p. i
|
article
|
| 8 |
Epidemiological and genetic characterization of measles virus circulating strains at Marseille, France during 2017–2019 measles outbreak
|
Jaafar, Rita
|
|
|
83 |
3 |
p. 361-370
|
article
|
| 9 |
Epidemiology and co-infection patterns in patients with respiratory tract infections in southern China between 2018 and 2020
|
Liang, Jingyi
|
|
|
83 |
3 |
p. e6-e8
|
article
|
| 10 |
Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms
|
Wu, Jian
|
|
|
83 |
3 |
p. 298-305
|
article
|
| 11 |
Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery
|
Yan, Xiquan
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 12 |
Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection
|
Rajamanickam, Anuradha
|
|
|
83 |
3 |
p. 339-346
|
article
|
| 13 |
Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity
|
Olea, Beatriz
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 14 |
Mouth care matters – A HAP prevention strategy
|
Garvey, Mark I.
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 15 |
One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection
|
Dimeglio, Chloé
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 16 |
Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21
|
Thangaraj, Jeromie Wesley Vivian
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 17 |
Potential impact of COVID-19 pandemic on escalating antimicrobial resistance in Pakistan
|
Rana, Muhammad Suleman
|
|
|
83 |
3 |
p. e12-e13
|
article
|
| 18 |
Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination
|
Raw, Rachael Kathleen
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 19 |
Procalcitonin use for the screening of bacterial infections in pregnant women in the emergency ward: A prospective study
|
Runyo, Florence
|
|
|
83 |
3 |
p. e4-e5
|
article
|
| 20 |
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study
|
Pezzati, Laura
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 21 |
Risk factors for IRIS in HIV-associated Pneumocystis-pneumonia following ART initiation
|
Kann, Gerrit
|
|
|
83 |
3 |
p. 347-353
|
article
|
| 22 |
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial
|
Mombelli, Matteo
|
|
|
83 |
3 |
p. 354-360
|
article
|
| 23 |
Successful case of adjunctive intravenous bacteriophage therapy to treat left ventricular assist device infection
|
Tkhilaishvili, Tamta
|
|
|
83 |
3 |
p. e1-e3
|
article
|
| 24 |
Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19
|
Mendez-Brito, Alba
|
|
|
83 |
3 |
p. 281-293
|
article
|
| 25 |
The impact of an antifungal stewardship team on voriconazole therapeutic drug monitoring in a UK tertiary hospital
|
Jones, M.
|
|
|
83 |
3 |
p. e9-e11
|
article
|
| 26 |
The role of Kingella kingae in pre-school aged children with bone and joint infections
|
Olijve, Laudi
|
|
|
83 |
3 |
p. 321-331
|
article
|
| 27 |
The surge in Covid related mucormycosis
|
Chandra, Somesh
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 28 |
Undetected carriage explains apparent Staphylococcus aureus acquisition in a non-outbreak healthcare setting
|
Price, James R
|
|
|
83 |
3 |
p. 332-338
|
article
|
| 29 |
Vertebral osteomyelitis in patients with Staphylococcus aureus bloodstream infection: Evaluation of risk factors for treatment failure
|
Jung, N
|
|
|
83 |
3 |
p. 314-320
|
article
|
| 30 |
Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
|
Tré-Hardy, Marie
|
|
|
83 |
3 |
p. 381-412
|
article
|
| 31 |
Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
|
KWOK, Kin On
|
|
|
83 |
3 |
p. 381-412
|
article
|
Journal description